Thessalus is focused on achieving significant risk-adjusted returns for investors through strategic transactions in middle and large market cap life sciences companies based in the U.S. and internationally. Target performance is 20-25% annual growth. Target performance met and exceeded since fund inception.

Dedicated to Client Service Thessalus believes its teams of domain experts and creative managers will deliver superior service and results to clients from all over the world."